Letter to the Editor
The role of RASSF proteins in modulating RAS driven lung tumors in vivo
Abstract
Sir, the recent editorial of our article describing the first animal model for KRAS-driven lung tumors in a RASSF1A-deficient background (1) succinctly and accurately describes our work. I would like to take the opportunity to elaborate and to describe some additional pertinent experiments.
